Theracos
21
0
0
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
4.8%
1 terminated/withdrawn out of 21 trials
95.2%
+8.7% vs industry average
29%
6 trials in Phase 3/4
95%
19 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension
Role: lead
Bexagliflozin Drug/Drug Interaction Study With Digoxin
Role: lead
Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
Role: lead
Bexagliflozin Efficacy and Safety Trial
Role: lead
Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Role: lead
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
Role: lead
Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus
Role: lead
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Role: lead
A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus
Role: lead
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Role: lead
Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Role: lead
Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus
Role: lead
Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects
Role: lead
Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment
Role: lead
Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
Role: lead
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Role: lead
Efficacy and Safety of THR-4109 in Obese Subjects
Role: lead
Absolute Bioavailability Study With Bexagliflozin
Role: lead
Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects
Role: lead
Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes
Role: lead